5 Polen Capital Bio-Techne Trades
Polen Capital's position in Bio-Techne is currently worth $1.04 Million. That's 0.00% of their equity portfolio (97th largest holding). Polen Capital started to build up the position in Bio-Techne in Q4 2023 and continued to invest until Q1 2024. Since then they sold 16.3 Thousand shares. The investor's estimated purchase price is $1.41 Million, resulting in a loss of 27%.
News about Bio-Techne Corp and Polen Capital
John L Higgins At Bio-Techne Capitalizes: Options Exercised, Resulting In $300K
Highlighted on July 10, it was unveiled in an SEC filing that Higgins, Director at Bio-Techne (NASDAQ: TECH ), executed a significant transaction involving t...
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be down...
What Makes Bio-Techne Corporation (TECH) an Investment Bet?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the sa...
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by SRS Capital Advisors Inc.
… of Bio-Techne Co. (NASDAQ: TECH – Get Rating) by 305.6% … . Analysts Set New Price Targets TECH has been the subject of … 4.04. Bio-Techne (NASDAQ: TECH – ...